Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2023

Open Access 18-11-2023 | Turner's Syndrome | Case report

Hemophilia A and factor V deficiency in a girl with Turner syndrome: a case report

Authors: Rawan Al khudari, Duaa Batesh, Roaa Habash, Othman Hamdn

Published in: Journal of Medical Case Reports | Issue 1/2023

Login to get access

Abstract

Background

Hemophilia is an X-linked, recessive inherited disease caused by a defect or deficiency of one of the coagulation factors (VIII or IX). It is considered a rare disease in females. One of the reasons that hemophilia affects females is Turner syndrome. Hemophilia with Turner syndrome is a very rare case, but the combination of Turner syndrome, hemophilia, and factor V deficiency is an isolated case that has never been recorded in the medical literature.

Case presentation

In our case, a 5-year-old Syrian girl presented with hemorrhage of gum, epistaxis, and short stature. The lab tests showed: prolonged activated partial thromboplastin time and prothrombin time with deficiency of factor V (1%) and factor VIII (1%). We diagnosed hemophilia A with factor V deficiency. In addition to short stature, the patient was noted to have spaced nipples and winged neck. We performed karyotyping that showed deletion of one X chromosome (45X0), Turner syndrome. There is no family history of hemophilia or any other genetic disease.

Conclusions

In females affected with hemophilia, karyotyping should be performed. It is very important not to exclude the possibility of a combination of deficiency of more than one clotting factor, and to note that deficiency of more than one factor does not necessarily increase the severity of bleeding compared with deficiency of a single factor.
Literature
2.
go back to reference Johnsen JM. Current challenges in hemophilia genetics and how they can be overcome. Nat Cardiovasc Res. 2022;1(10):867–8.CrossRef Johnsen JM. Current challenges in hemophilia genetics and how they can be overcome. Nat Cardiovasc Res. 2022;1(10):867–8.CrossRef
3.
go back to reference Agnieszka B, et al. Severe haemophilia A in a preterm girl with Turner syndrome: case report—a diagnostic and therapeutic challenge for a paediatrician (Part 2). Ital J Pediatr. 2021;47(1):157.CrossRefPubMedPubMedCentral Agnieszka B, et al. Severe haemophilia A in a preterm girl with Turner syndrome: case report—a diagnostic and therapeutic challenge for a paediatrician (Part 2). Ital J Pediatr. 2021;47(1):157.CrossRefPubMedPubMedCentral
4.
go back to reference Miller CH, Bean CJ. Genetic causes of haemophilia in women and girls. Haemophilia. 2021;27(2):e164–79.CrossRefPubMed Miller CH, Bean CJ. Genetic causes of haemophilia in women and girls. Haemophilia. 2021;27(2):e164–79.CrossRefPubMed
5.
go back to reference Shao Y, et al. Low factor V level ameliorates bleeding diathesis in patients with combined deficiency of factor V and factor VIII. Blood. 2019;134(20):1745–54.CrossRefPubMed Shao Y, et al. Low factor V level ameliorates bleeding diathesis in patients with combined deficiency of factor V and factor VIII. Blood. 2019;134(20):1745–54.CrossRefPubMed
6.
go back to reference Mansouritorgabeh H, et al. Haemorrhagic symptoms in patients with combined factors V and VIII deficiency in north-eastern Iran. Haemophilia. 2004;10(3):271–5.CrossRefPubMed Mansouritorgabeh H, et al. Haemorrhagic symptoms in patients with combined factors V and VIII deficiency in north-eastern Iran. Haemophilia. 2004;10(3):271–5.CrossRefPubMed
7.
go back to reference Mehta P, Reddivari AKR. Hemophilia. Treasure Island: StatPearls Publishing; 2021. Mehta P, Reddivari AKR. Hemophilia. Treasure Island: StatPearls Publishing; 2021.
9.
go back to reference Berendt A, et al. Severe haemophilia A in a preterm girl with turner syndrome—a case report from the prenatal period to early infancy (part I). Ital J Pediatr. 2020;46(1):125.CrossRefPubMedPubMedCentral Berendt A, et al. Severe haemophilia A in a preterm girl with turner syndrome—a case report from the prenatal period to early infancy (part I). Ital J Pediatr. 2020;46(1):125.CrossRefPubMedPubMedCentral
10.
go back to reference Gravholt CH, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017;177(3):G1-g70.CrossRefPubMed Gravholt CH, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017;177(3):G1-g70.CrossRefPubMed
11.
go back to reference Baxter L, et al. Recombinant growth hormone for children and adolescents with Turner syndrome. Cochrane Database Syst Rev. 2007(1): CD003887. Baxter L, et al. Recombinant growth hormone for children and adolescents with Turner syndrome. Cochrane Database Syst Rev. 2007(1): CD003887.
12.
go back to reference van Pareren YK, et al. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab. 2003;88(3):1119–25.CrossRefPubMed van Pareren YK, et al. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab. 2003;88(3):1119–25.CrossRefPubMed
13.
go back to reference Ranke MB, et al. Analyses from a centre of short- and long-term growth in Turner’s syndrome on standard growth hormone doses confirm growth prediction algorithms and show normal IGF-I levels. Horm Res Paediatr. 2012;77(4):214–21.CrossRefPubMed Ranke MB, et al. Analyses from a centre of short- and long-term growth in Turner’s syndrome on standard growth hormone doses confirm growth prediction algorithms and show normal IGF-I levels. Horm Res Paediatr. 2012;77(4):214–21.CrossRefPubMed
14.
15.
go back to reference Zheng C, et al. Molecular basis of LMAN1 in coordinating LMAN1-MCFD2 cargo receptor formation and ER-to-Golgi transport of FV/FVIII. Blood. 2010;116(25):5698–706.CrossRefPubMedPubMedCentral Zheng C, et al. Molecular basis of LMAN1 in coordinating LMAN1-MCFD2 cargo receptor formation and ER-to-Golgi transport of FV/FVIII. Blood. 2010;116(25):5698–706.CrossRefPubMedPubMedCentral
16.
go back to reference Frey NV, Porter DL. Hematopoietic stem cell transplantation: ASBMT/CIBMTR 2010 tandem meeting highlights and discussion. Am J Hematol. 2010;85(7):519.CrossRefPubMedCentral Frey NV, Porter DL. Hematopoietic stem cell transplantation: ASBMT/CIBMTR 2010 tandem meeting highlights and discussion. Am J Hematol. 2010;85(7):519.CrossRefPubMedCentral
17.
go back to reference Patel AJ, et al. Successful percutaneous coronary intervention in a patient with combined deficiency of FV and FVIII due to novel compound heterozygous mutations in LMAN1. Haemophilia. 2013;19(4):607–10.CrossRefPubMedPubMedCentral Patel AJ, et al. Successful percutaneous coronary intervention in a patient with combined deficiency of FV and FVIII due to novel compound heterozygous mutations in LMAN1. Haemophilia. 2013;19(4):607–10.CrossRefPubMedPubMedCentral
Metadata
Title
Hemophilia A and factor V deficiency in a girl with Turner syndrome: a case report
Authors
Rawan Al khudari
Duaa Batesh
Roaa Habash
Othman Hamdn
Publication date
18-11-2023
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2023
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-023-04215-2

Other articles of this Issue 1/2023

Journal of Medical Case Reports 1/2023 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.